Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-20T06:56:52.196Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Human Parovirus B19 Infection: Lack of Transmission From a Chronically Infected Patient to Hospital Staff

Published online by Cambridge University Press:  21 June 2016

Deloris E. Koziol ,
Gary Kurtzrnan ,
Jamshed Ayub ,
Neal S. Young  and
David K. Henderson
Deloris E. Koziol*
Affiliation:
Hospital Epidemiology Service, National Institutes of Health, Bethesda, Maryland
Gary Kurtzrnan
Affiliation:
Warren G. Magnuson Clinical Center, and the Cell Biology Section, Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
Jamshed Ayub
Affiliation:
Warren G. Magnuson Clinical Center, and the Cell Biology Section, Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
Neal S. Young
Affiliation:
Warren G. Magnuson Clinical Center, and the Cell Biology Section, Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
David K. Henderson
Affiliation:
Hospital Epidemiology Service, National Institutes of Health, Bethesda, Maryland
*
Building 10, Room 4A 21, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the potential for nosocomial spread of parvovirus B19 from a chronically infected patient.

Design:

Employees exposed to the index case and control (unexposed) employees were evaluated by baseline and follow up parvovirus B19 serologies and hematologic assessments, and completed baseline and follow up epidemiologic questionnaires.

Setting:

A chronically infected patient was hospitalized on a hematology ward in a research referral hospital for 3.5 weeks prior to a diagnosis of parvovirus B19 infection and the institution of isolation precautions.

Methods:

Sera were screened for parvovirus B19 DNA (dot blot analysis), and IgG and IgM anti-B19 antibodies (capture immunoassay). Hematologic assessment included CBC, differential, and reticulocyte count.

Results:

The index case had parvovirus B19 DNA at approximately lo6 genome copies per ml of serum, elevated IgM and low levels of IgG B19 antibodies. Of the 21 exposed staff, 11 (52%) had IgG B19 antibodies and were immune; of the 8 unexposed staff, 6 (75%) had IgG B19 antibodies. No employees developed IgM B19 antibodies, B19 DNA, hematologic abnormalities, or clinical symptoms.

Conclusions:

In contrast to reports of documented nosocomial transmission of B19 parvovirus from patients in transient aplastic crisis, nosocomial transmission did not occur-even in the absence of isolation precautions-presumably from the lower level of B19 viremia in our chronically infected (rather than acutely infected) patient.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 6 , June 1992 , pp. 343 - 348
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Cossart, YE, Field, AM, Cant, B, Widdows, D. Parvovirus-like particles in human sera. Lancet. 1975;i:72–73.Google Scholar
2. Shneerson, JM, Mortimer, PP, Vandervelde, EM. Febrile illness due to a parvovirus. Br Med J. 1980;280:1580–1581.CrossRefGoogle ScholarPubMed
3. Anderson, MJ. The emerging story of a human parvovirus-like agent. J Hyg Camb. 1982;89:1–8.CrossRefGoogle ScholarPubMed
4. Cohen, BJ, Mortimer, PP, Pereira, MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg Camb. 1983;91:113–130.Google Scholar
5. Pattison, JR, Jones, SE, Hodgson, J, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Luncet. 1981;i:664–665.Google Scholar
6. Serjeant, GR, Topley, JM, Mason, K, et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981;ii:595–597.Google Scholar
7. Mortimer, PP. Hynothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. J Clin Pathol. 1983;36:445–448.Google Scholar
8. Davidson, RJ, Brown, T, Wiseman, D. Human parvovirus infection and aplastic crisis in hereditary spherocytosis. J Infect. 1984;9:298–300.CrossRefGoogle ScholarPubMed
9. Green, DH, Bellingham, AJ, Anderson, MJ. Parvovirus infection in a family associated with aplastic crisis in an affected sibling pair with hereditary spherocytbsis. J Clin Pathol. 1984;37:1144–1146.Google Scholar
10. Hanada, T. Koike, K, Takeya, T, Naeasawa, T, Matsunaga, Y, Takita, H. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. By J Haematol. 1988;70:113–115.Google Scholar
11. Duncan, JR, Potter, CG, Cappellini, MD, Kurtz, JB, Anderson, MJ, Weatherall, DJ. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet. 1983;ii:14–16.CrossRefGoogle Scholar
12. Bertrand, Y, Lefrere, JJ, Leverger, G, et al. Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia. Lancet. 1985;11:382–383.CrossRefGoogle Scholar
13. Anderson, MJ, Jones, SE, Fisher-Hoch, SP et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet. 1983;i:1378.CrossRefGoogle Scholar
14. Anderson, MJ, Pattison, JR The human parvovirus. Brief review. Arch Virol. 1984;82:137–148.Google Scholar
15. Plummer, FA, Hammond, GW, Forward, K, et al. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med. 1985;313:74–79.Google Scholar
16. Thum, J. Human parvovirus B19: historical and clinical review. Rev Infect Dis. 1988;10:1005–1011.Google Scholar
17. Feder, HM. Anderson, I. Fii disease. A brief review of infections in childhood, in adulthood, and in pregnancy. Arch Intern Med. 1989;149:2176–2178.CrossRefGoogle Scholar
18. Brown, T, Anand, A, Ritchie, LD, Clewley, JP, Reid, TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984;11:1033–1034.Google Scholar
19. Knott, PD. Welply, GAC. Serologically moved intrauterine infection with parvovirus. Br Med J. 1984;289:1660.Google Scholar
20. Woemle, CH, Anderson, LJ, Tattersall, P, Davison, JM. Human parvovirus B19 infection during pregnancy. J Infect Dis. 1987;156:17–20.Google Scholar
21. Reid, DM, Reid, TM, Brown, T, Rennie, JAN, Eastmond, CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet. 1985;i:422–425.Google Scholar
22. White, DG, Woolf, AD, Mortimer, PP, Cohen, BJ, Blake, DR, Bacon, PA. Human parvovirus arthropathy. Luncet. 1985;i:419–421.Google Scholar
23. Woolf, AD, Campion, GV, Chishick, A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989;149:1153–1156.CrossRefGoogle ScholarPubMed
24. Van Horn, DK, Mot-timer, PP, Young, N, Hanson, GR. Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia. Am J Pediatr Hematol Oncol. 1986;8:235–239.CrossRefGoogle ScholarPubMed
25. Kurtzman, GJ, Ozawa, K, Cohen, B, Hanson, G, Oseas, R, Young, NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 1987;317:287–294.Google Scholar
26. Kurtzman, GJ, Cohen, B, Meyers, P, Amunullah, A, Young, NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet. 1988;1:1159–1162.Google Scholar
27. Smith, MA, Shah, NR, Lobel, JS, Cera, PJ, Gary, GW, Anderson, LJ. Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy. Clin Pediatr. 1988;27:383–386.Google Scholar
28. Carstensen, H, Ørnvold, K, Cohen, BJ. Human parvovirus B19 infection associated with prolonged erythroblastopenia in a leukemic child. Pediatr Infect Dis J 1989;8:56.CrossRefGoogle Scholar
29. Graeve, JL, de Alarcon, PA, Naides, SJ. Parvovitus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol. 1989;11:441–444.Google Scholar
30. Weiland, HT, Salimans, MMM, Fibbe, WE, Kluin, PM, Cohen, BJ. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant recipient. Br J Haematol. 1989;71:300.Google Scholar
31. Chrystie, IL, Almeida, JD, Welch, J. Case report: electron microscopic detection of human parvovirus (B19) in a patient with HIV infection. J Med Virol. 1990;30:249–252.Google Scholar
32. Rao, SP, Miller, ST, Cohen, BJ. Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission. Am J Pediatr Hematol Oncol. 1990;12:194–197.Google Scholar
33. Mitchell, SA, Welch, JM, Weston-Smith, S, Nicholson, F, Bradbeer, CS. Parvovirus infection and anaemia in a patient with AIDS: case report. Genitourin Med. 1990;66:95–96.Google Scholar
34. Koch, WC. Massev, G. Russell, CE. Adler SE Manifestations and treatment' of human parvovirus B19 infection in immunocompromised patients. J Pediatr. 1990;116:355–359.Google Scholar
35. Frickhofen, N. Abkowitz, IL. Safford, M. et al. Persistent B19 parvovirus infection in patients infected with human immunodeticiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med. 1990;113:926–933.Google Scholar
36. Anderson, MJ, Higgins, PG, Davis, LR, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985;152:257–265.Google Scholar
37. Centers for Disease Control. Risks associated with human parvovirus B19 infection. MMWR. 1989;38:81–97.Google Scholar
38. Chorba, T, Coccia, P, Holman, RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis. 1986;154:383–393.Google Scholar
39. Frickhofen, N, Young, NS. Persistent parvovirus B19 infections in humans. Microb Pathog. 1989;7:319–327.Google Scholar
40. Evans, JPM, Rossiter, MA, Kumaran, TO, Marsh, GW. Human parvovirus aplasia: case due to cross infection in a ward. Br Med J. 1984;288:681.Google Scholar
41. Bell, LM, Naides, SJ, Stoffman, P, Hodinka, RL, Plotkin, SA. Human patvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med. 1989;321:485–491.Google Scholar
42. Kurtzman, G, Frickhofen, N, Kimball, J, Jenkins, DW, Nienhuis, AW, Young, NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunglobulin therapy. N Engl J Med. 1989;321:519–523.Google Scholar
43. Clewley, JP. Detection of human parvovirus using a molecularly cloned probe. J Med Virol. 1985;15:173–181.Google Scholar
44. Ozawa, K, Young, N. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol. 1987;61:2627–2630.Google Scholar
45. Lentner, C, ed. Geigy Scientific Tables. Volume 2. 8th ed. West Caldwell, NJ: Medical Education Division, Ciba-Geigy Corporation; 1982.Google Scholar
46. Mortimer, PP, Humphries, RK, Moore, JG, Purcell, RH, Young, NS. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature. 1983;302:426–429.Google Scholar
47. Young, N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol. 1988;25:159–172.Google Scholar
48. Ozawa, K, Kurtzman, G, Young, N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood. 1987;70:384–391.Google Scholar
49. Saarinen, UM, Chorba, TL, Tattersall, P, et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986;67:1411–1417.Google Scholar
50. Anderson, LJ, Hurwitz, ES. Human parvovirus B19 and pregnancy. Clin Perinatol. 1988;15:273–286.Google Scholar
51. Rodis, JF, Hovick, TJ, Quinn, DL, Rosengren, SS, Tattersall, P. Human parvovirus infection in pregnancy. Obstet Gynecol. 1988;72:733–738.Google ScholarPubMed
52. Van Elsacker-Niele, AMW, Salimans, MMM, Weiland, HT, Vermey-Keers, CHR, Anderson, MJ, Versteeg, J. Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol. 1989;96:768–775.Google Scholar
53. Shmoys, S, Kaplan, C. Parvovirus and pregnancy. Clin Obstet Gynecol. 1990;33:268–275.Google Scholar
54. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J. 1990;300:1166–1170.Google Scholar
55. Lefrère, JJ, Boutard, P, Couroucé, A-M, Lacaze, T, Girot, R. Familial human parvovirus infections. Lancet. 1985;ii:333–334.Google Scholar
56. Lefrère, JJ, Couroué, AM, Muller, J-Y, Clark, M, Soulier, J-P Human parvovirus and purpura. Lancet. 1985;ii:730.Google Scholar
57. Morinet, F, Monsuez, JJ, Roger, P, Perol, Y. Parvovitus B19 associated with pseudoappendicitis. Lancet. 1987;ii:1466.Google Scholar
58. Hamon, MD, Newland, AC, Anderson, MJ. Severe aplastic anaemia after parvovirus infection in the absence of underlying haemolytic anaemia. J Clin Pathol. 1988;41:1242–1246.CrossRefGoogle ScholarPubMed
59. Wodzinski, MA, Lilleyman, JS. Transient erythroblastopenia of childhood due to human parvovirus B19 infection. BY J Haematol. 1989;73:127–131.Google Scholar
60. Belloy, M, Morinet, F, Blondin, G, Couroucé, A-M, Peyrol, Y, Vilmer, E. Erythroid hypoplasia due to chronic infection with parvovirus B19. N Engl J Med. 1990;322:633–634.Google Scholar
61. Boruchoff, SE, Woda, BA, Pihan, GA, Durbin, WA, Burstein, D, Blacklow, NR Parvovirus B19-associated hemoohanocytic syndrome. Arch Intern Med. 1990;150:897–899.Google Scholar
62. Mortimer, PP, Luban, NLC, Kelleher, JF, Cohen, BJ. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet. 1983;11:482–484.Google Scholar
63. Williams, MD, Cohen, BJ, Beddall, AC, Pasi, KJ, Mortimer, PP, Hill, FGH. Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang. 1990;58:177–181.Google Scholar
64. Cohen, BJ, Couroucé, A-M, Schwarz, TF, Okochi, K, Kurtzman, GJ. Laboratory infection with parvovirus B19. J Clin Pathol. 1988;9:1027–1028.Google Scholar
65. Noel, GJ, Gary, GW. Human parvovirus B19 infection in a day care worker. Pediatr Infect Dis J. 1988;7:880.Google Scholar
66. Gillespie, SM, Cartter, ML, Asch, S, et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA. 1990;263:2061–2065.Google Scholar
67. Anderson, LJ. Role of parvovirus B19 in human disease. Adiatr Infect Dis J. 1987;6:711–718.Google Scholar
68. Naides, SJ. Infection control measures for human parvovirus B19 in the hospital setting. Infect Control Hosp Epidemiol. 1989;10:326–329.Google Scholar